Cargando…

Electroencephalography as a Non-Invasive Biomarker of Alzheimer’s Disease: A Forgotten Candidate to Substitute CSF Molecules?

Biomarkers for disease diagnosis and prognosis are crucial in clinical practice. They should be objective and quantifiable and respond to specific therapeutic interventions. Optimal biomarkers should reflect the underlying process (pathological or not), be reproducible, widely available, and allow m...

Descripción completa

Detalles Bibliográficos
Autores principales: Monllor, Paloma, Cervera-Ferri, Ana, Lloret, Maria-Angeles, Esteve, Daniel, Lopez, Begoña, Leon, Jose-Luis, Lloret, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509134/
https://www.ncbi.nlm.nih.gov/pubmed/34639229
http://dx.doi.org/10.3390/ijms221910889
_version_ 1784582261600944128
author Monllor, Paloma
Cervera-Ferri, Ana
Lloret, Maria-Angeles
Esteve, Daniel
Lopez, Begoña
Leon, Jose-Luis
Lloret, Ana
author_facet Monllor, Paloma
Cervera-Ferri, Ana
Lloret, Maria-Angeles
Esteve, Daniel
Lopez, Begoña
Leon, Jose-Luis
Lloret, Ana
author_sort Monllor, Paloma
collection PubMed
description Biomarkers for disease diagnosis and prognosis are crucial in clinical practice. They should be objective and quantifiable and respond to specific therapeutic interventions. Optimal biomarkers should reflect the underlying process (pathological or not), be reproducible, widely available, and allow measurements repeatedly over time. Ideally, biomarkers should also be non-invasive and cost-effective. This review aims to focus on the usefulness and limitations of electroencephalography (EEG) in the search for Alzheimer’s disease (AD) biomarkers. The main aim of this article is to review the evolution of the most used biomarkers in AD and the need for new peripheral and, ideally, non-invasive biomarkers. The characteristics of the EEG as a possible source for biomarkers will be revised, highlighting its advantages compared to the molecular markers available so far.
format Online
Article
Text
id pubmed-8509134
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85091342021-10-13 Electroencephalography as a Non-Invasive Biomarker of Alzheimer’s Disease: A Forgotten Candidate to Substitute CSF Molecules? Monllor, Paloma Cervera-Ferri, Ana Lloret, Maria-Angeles Esteve, Daniel Lopez, Begoña Leon, Jose-Luis Lloret, Ana Int J Mol Sci Review Biomarkers for disease diagnosis and prognosis are crucial in clinical practice. They should be objective and quantifiable and respond to specific therapeutic interventions. Optimal biomarkers should reflect the underlying process (pathological or not), be reproducible, widely available, and allow measurements repeatedly over time. Ideally, biomarkers should also be non-invasive and cost-effective. This review aims to focus on the usefulness and limitations of electroencephalography (EEG) in the search for Alzheimer’s disease (AD) biomarkers. The main aim of this article is to review the evolution of the most used biomarkers in AD and the need for new peripheral and, ideally, non-invasive biomarkers. The characteristics of the EEG as a possible source for biomarkers will be revised, highlighting its advantages compared to the molecular markers available so far. MDPI 2021-10-08 /pmc/articles/PMC8509134/ /pubmed/34639229 http://dx.doi.org/10.3390/ijms221910889 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Monllor, Paloma
Cervera-Ferri, Ana
Lloret, Maria-Angeles
Esteve, Daniel
Lopez, Begoña
Leon, Jose-Luis
Lloret, Ana
Electroencephalography as a Non-Invasive Biomarker of Alzheimer’s Disease: A Forgotten Candidate to Substitute CSF Molecules?
title Electroencephalography as a Non-Invasive Biomarker of Alzheimer’s Disease: A Forgotten Candidate to Substitute CSF Molecules?
title_full Electroencephalography as a Non-Invasive Biomarker of Alzheimer’s Disease: A Forgotten Candidate to Substitute CSF Molecules?
title_fullStr Electroencephalography as a Non-Invasive Biomarker of Alzheimer’s Disease: A Forgotten Candidate to Substitute CSF Molecules?
title_full_unstemmed Electroencephalography as a Non-Invasive Biomarker of Alzheimer’s Disease: A Forgotten Candidate to Substitute CSF Molecules?
title_short Electroencephalography as a Non-Invasive Biomarker of Alzheimer’s Disease: A Forgotten Candidate to Substitute CSF Molecules?
title_sort electroencephalography as a non-invasive biomarker of alzheimer’s disease: a forgotten candidate to substitute csf molecules?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509134/
https://www.ncbi.nlm.nih.gov/pubmed/34639229
http://dx.doi.org/10.3390/ijms221910889
work_keys_str_mv AT monllorpaloma electroencephalographyasanoninvasivebiomarkerofalzheimersdiseaseaforgottencandidatetosubstitutecsfmolecules
AT cerveraferriana electroencephalographyasanoninvasivebiomarkerofalzheimersdiseaseaforgottencandidatetosubstitutecsfmolecules
AT lloretmariaangeles electroencephalographyasanoninvasivebiomarkerofalzheimersdiseaseaforgottencandidatetosubstitutecsfmolecules
AT estevedaniel electroencephalographyasanoninvasivebiomarkerofalzheimersdiseaseaforgottencandidatetosubstitutecsfmolecules
AT lopezbegona electroencephalographyasanoninvasivebiomarkerofalzheimersdiseaseaforgottencandidatetosubstitutecsfmolecules
AT leonjoseluis electroencephalographyasanoninvasivebiomarkerofalzheimersdiseaseaforgottencandidatetosubstitutecsfmolecules
AT lloretana electroencephalographyasanoninvasivebiomarkerofalzheimersdiseaseaforgottencandidatetosubstitutecsfmolecules